119 related articles for article (PubMed ID: 2732458)
21. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
Borgström E; Wahren B
J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
[TBL] [Abstract][Full Text] [Related]
22. Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression.
Langkilde NC; Wolf H; Clausen H; Kjeldsen T; Orntoft TF
Cancer; 1992 Jan; 69(1):219-27. PubMed ID: 1727666
[TBL] [Abstract][Full Text] [Related]
23. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
Busch C; Malmström PU; Norlen BJ; Sällström J; Brodin T; Lundblad A
Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
[TBL] [Abstract][Full Text] [Related]
25. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder.
Juhl BR; Hartzen SH; Hainau B
Cancer; 1986 May; 57(9):1768-75. PubMed ID: 2420436
[TBL] [Abstract][Full Text] [Related]
26. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
Askari A; Colmenares E; Saberi A; Jarman WD
J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
[TBL] [Abstract][Full Text] [Related]
27. [Correlations between grading and presence of blood group isoantigens in papillary urothelial-cell carcinoma of the bladder with low grade malignancy].
Mattarozzi A; Zanella L; Bacchini P; Bertoni F; Ferramosca B
Pathologica; 1985; 77(1050):395-400. PubMed ID: 3834371
[No Abstract] [Full Text] [Related]
28. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
[TBL] [Abstract][Full Text] [Related]
29. [A B H isoantigens in bladder cancer. Preliminary study].
Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
[No Abstract] [Full Text] [Related]
30. Blood group antigens in epithelial tumours of the urinary bladder.
Marek J; Hradec E; Hanus M; Smolová H
Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171
[TBL] [Abstract][Full Text] [Related]
31. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
Yamada T; Fukui I; Yokokawa M; Oshima H
Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
[TBL] [Abstract][Full Text] [Related]
32. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
Richie JP; Blute RD; Waisman J
J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
[TBL] [Abstract][Full Text] [Related]
33. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
[TBL] [Abstract][Full Text] [Related]
34. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
Das G; Glashan RW
J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
[TBL] [Abstract][Full Text] [Related]
35. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
[TBL] [Abstract][Full Text] [Related]
36. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
Malmström PU; Busch C; Norlen BJ; Andersson B
Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
[TBL] [Abstract][Full Text] [Related]
37. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
Das G
Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
[No Abstract] [Full Text] [Related]
38. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
Gelabert Mas A; Corominas J; Arango O
Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
[No Abstract] [Full Text] [Related]
39. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
Borella T; Loro M; Dato I; Merlo F; Giudici M
Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
[TBL] [Abstract][Full Text] [Related]
40. A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
Karlsen S; Jordfald G; Svaar H
Urol Int; 1984; 39(3):150-3. PubMed ID: 6740805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
